A novel and simple immunocapture assay for determination of gelatinase-B (MMP-9) activities in biological fluids: Saliva from patients with Sjogren's syndrome contain increased latent and active gelatinase-B levels

Matrix Biology

Volumn 17, Issue 8-9, 1998, Pages 657-665

  Hanemaaijer, Roeland ^a   Visser, Hetty ^a   Konttinen, Yrjö T ^b   Koolwijk, Pieter ^a   Verheijen, Jan H ^a  

^a TNO   (Netherlands)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Activity assay; Gelatinase B; Matrix metalloproteinases (MMP); Sjogren's syndrome; Urokinase

Indexed keywords

COLLAGEN; ENZYME ANTIBODY; GELATINASE A; GELATINASE B; MONOCLONAL ANTIBODY; PROUROKINASE; REAGENT; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ANIMAL EXPERIMENT; ARTICLE; CLINICAL ARTICLE; COLORIMETRY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME MODIFICATION; ENZYME SUBSTRATE; EQUIPMENT; FEMALE; HUMAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; SALIVA LEVEL; SJOEGREN SYNDROME; SPECTROPHOTOMETER;

ANIMALIA;

EID: 0032428256     PISSN: 0945053X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0945-053X(98)90116-0     Document Type: Article

References (20)

1. Baker, T., Tickle, S., Wasan, H., Docherty, A., Isenberg, D., and Waxman, J.: Serum metalloproteinases and their inhibitors: markers for malignant potential. British Journal of Cancer, 70: 506-512, 1994
2. Beekman, B., Drijfhout, J., Bloemhoff, W., Ronday, H., Tak, P., and Koppele, J.: Convenient fluorometric assay for matrix metalloproteinase activity and its application in biological media. FEBS Letters 390: 221-225, 199
3. Birkedalhansen, H., Moore, W., Bodden, M., Windsor, L., Birkedalhansen, B., Decarlo, A., and Engler, J.: Matrix-metalloproteinases: a review. Crit. Rev. Oral Biol.Med. 4: 197-250, 1993
4. Bos, R., Siegel, K. Otter, M. and Nieuwenhuizen, W.: Production and characterization of a set of monoclonal antibodies against tissue-type plasminogen activator (t-PA). Fibrinolysis 6: 173-182, 1992
5. Cawston, T.: Metalloproteinase inhibitors and the prevention of connective tissue breakdown. Pharmacology & Therapeutics 70: 163-182, 1996
6. Gohji, K., Fujimoto, N., Komiyama, T., Fujii, A., Ohkawa, J., Kamidono, S., and Nakajima, M.: Elevation of serum levels of matrix metalloproteinase-2 and -3 as new predictors of recurrence in patients with urothelial carcinoma. Cancer 78: 2379-2387, 1996
7. Hanemaaijer, R., Koolwijk, P., le Clercq, L., de Vree, W., and van Hinsbergh, V.: Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells - effects of tumour necrosis factor-alpha, interleukin-1 and phorbol ester. Biochem. J. 296: 803-809, 1993
8. Hanemaaijer, R., Sorsa, T., Konttinen, Y.T., Ding, Y., Kylmäniemi, M., Visser, H., van Hinsbergh, V.W.M., Helaakoski, T., Kainulainen, T., Rönkä, H., Tschesche, H. and Salo, T.: Matrix Metalloproteinase-8 is Expressed in Rheumatoid Synovial Fibroblasts and Endothelial Cells. Regulation by TNF and Doxycycline. J. Biol. Cbem. 272: 31504-31509, 1997
9. Konttinen, Y.T., Kangaspunta, P., Lindy, O., Takagi, M., Sorsa, T., Segerberg, M., Eisen, A.Z. and Tschesche, H.: Collagenase in Sjögren's syndrome. Ann. Rheum. Dis. 53: 836-839, 1994
10. Liotta, L. A., Steeg, P. S. and Stetlerstevenson, W. G.: Cancer metastasis and angiogenesis:An imbalance of positive and negative regulation. Cell 64: 327-336, 1991.
11. Mahmoud, M. and Gaffney, P.J.: Bioimmunoassay (BIA) of tissue plasminogen activator tPA and its specific inhibitor tPA. Thromb. Haemost. 53: 356-359, 1985
12. Murawaki, Y., Koda, M., Yamada, S., Kawasaki, H., Shima, H., and Burkhardt, H.: Serum collagenase activity in patients with chronic liver disease. J. Hepatol. 18: 328-334, 1993
13. Murray, G., Duncan, M., Oneil, P., Melvin, W. and Fothergill, J.: Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer. Nature Med. 2: 461-462, 1996.
14. Nagase, H. and Fields, G.: Human matrix metalloproteinase specificity studies using collagen sequence- based synthetic peptides. Biopolymers 40: 399-416, 1996.
15. Shingleton, W., Hodges, D., Brick, P., and Cawston, T.: Collagenase: A key enzyme in collagen turnover. Biochemistry and Cell Biology. Biochim. Biol. Cell. 74: 759-775, 1996.
16. Sorsa, T., Salo, T., Koivunen, E., Tyynela, J., Konttinen, Y., Bergmann, U., Tuuttila, A., Niemi, E., Teronen, O., Heikkila, P., Tschesche, H., Leinonen, J., Osman, S., and Stenman, U.: Activation of type IV procollagenases by human tumor- associated trypsin-2. J. Biol. Chem. 272: 21067-21074, 1997.
17. Talal, N.: Recent developments in the immunology of Sjögren's syndrome (autoimmune exocrinopathy). Scan. J. Rheumatol. Suppl. 61: 76-82, 1986
18. Torii, A., Kodera, Y., Uesaka, K., Hirai, T., Yasui, K., Morimoto, T., Yamamura, Y., Kato, T., Hayakawa, T., Fujimoto, N., and Kito, T.: Plasma concentration of matrix metalloproteinase 9 in gastric cancer. Brit. J. Surg. 84: 133-136, 1997.
19. Verheijen, J., Nieuwenbroek, N., Beekman, B., Hanemaaijer, R., Verspaget, H., Ronday, H., and Bakker, A.: Modified proenzymes as artificial substrates for proteolytic enzymes: Colorimetric assay of bacterial collagenase and matrix metal-loproteinase activity using modified pro-urokinase. Biochem. J. 323: 603-609, 1997.
20. Zhang, J., Fujimoto, N., Iwata, K., Sakai, T., Okada, Y., and Hayakawa, T.: A one-step sandwich enzyme immunoassay for human matrix metalloproteinase-1 (interstitial collagenase) using monoclonal antibodies. Clinica Chimica Acta 219: 1-14, 1993.